Neck News and Research

RSS

Prophylactic PEG placement prior to HNC therapy associated with high rate of non use

Impairment of oral intake occurs in the majority of patients with head and neck cancer (HNC) receiving chemoradiotherapy. Placement of prophylactic percutaneous endoscopic gastrostomy (PEG) tube in asymptomatic newly diagnosed HNC before chemoradiation is a common practice in some centers. In some studies, PEG has been associated with a decrease in treatment related weight loss in patients with HNC, but no studies have examined the utilization rate.

16 Mar 2011

Researchers discover new key component in lung cancer spread

Researchers discovered a new, key component in the spread of lung cancer as well as a likely way to block it with drugs now in clinical trial. The study was published today (Monday, March 14) in the Journal of Clinical Investigation.

15 Mar 2011

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

10 Mar 2011

Brain implant surgery can improve life for people with cervical dystonia

Implanting electrodes into a pea-sized part of the brain can dramatically improve life for people with severe cervical dystonia - a rare but extremely debilitating condition that causes painful, twisting neck muscle spasms - according to the results of a pilot study led by Jill Ostrem, MD and Philip Starr, MD PhD at the University of California, San Francisco.

9 Mar 2011

Romney: Federal health reform worse than Mass. plan

News outlets covered a major political speech by former Mass. Gov. Mitt Romney on Saturday.

6 Mar 2011

BNCT treatment proves effective in treating recurrent head, neck cancer

Biologically targeted BNCT treatment is based on producing radiation inside a tumour using boron-10 and thermal neutrons. Boron-10 is introduced into cancer cells with the help of a special carrier substance (phenylalanine), after which the tumour is irradiated with lowenergy neutrons.

5 Mar 2011

Amgen acquires BioVex Group

Harris & Harris Group, Inc. notes that Amgen and BioVex Group, Inc., today announced the completion of the acquisition of BioVex Group, Inc.

4 Mar 2011

Electrical stimulation may help bring back the voice of stroke patients

A Virginia Tech College of Engineering researcher is seeking a new way to help those who are unable to speak to find their voice. But this isn't "The King's Speech," the Academy Award-winning film about a British royal undergoing speech therapy to battle a stammer. Instead, Alexander Leonessa wants to help bring back the voice of stroke patients and others who have suffered paralysis of the vocal folds, through electrical stimulation.

4 Mar 2011

New study examines boxing injuries among children and adolescents from 1990 to 2008

The risk and nature of injury in the sport of boxing has generated a great deal of controversy in the medical community, especially in relation to youth boxing. A new study, conducted by researchers in the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital, examined boxing injuries among participants 6 years of age and older from 1990 to 2008.

3 Mar 2011

New report finds 58% drop in CLABSIs in hospital intensive care units

A new report issued today by the Centers for Disease Control and Prevention showed a significant decrease in certain infections over the past nine years. The report found that central line associated bloodstream infections occurring in hospital intensive care units dropped by 58 percent between 2001 and 2009.

2 Mar 2011

IRX Therapeutics signs research collaboration agreement with world's leading pharma companies

IRX Therapeutics, a developer of immune therapies to make cancer treatments better, announced today it has signed a research collaboration agreement with one of the world's leading research-based pharmaceutical companies.

1 Mar 2011

Radiologists develop new non-surgical post-mortem technique

A new non-surgical post-mortem technique that has the potential to revolutionise the way autopsies are conducted around the world has been pioneered by forensic pathologists and radiologists at the University of Leicester in collaboration with the University Hospitals of Leicester NHS Trust.

1 Mar 2011

ADC announces RNAscope technology clinical study results for HPV-associated head and neck cancers

Advanced Cell Diagnostics, Inc. today announced the results of its clinical study utilizing RNAscope technology to detect human papillomavirus E6/E7 mRNA in routine clinical specimens of head and neck cancer.

From Advanced Cell Diagnostics 1 Mar 2011

Depression negatively impacts outcomes of care in patients with CRS: New research

Depression is a common problem in patients with chronic rhinosinusitis and negatively impacts patients' symptom burden, ability to function, and quality of life, according to new research published in the March 2011 issue of Otolaryngology - Head and Neck Surgery.

1 Mar 2011

Affymetrix introduces new GeneChip miRNA 2.0 Array

Affymetrix, Inc. today launched the GeneChip miRNA 2.0 Array. This enhanced version of its best-in-class microRNA interrogation solution will support the research community's pursuit of personalized medicine by accelerating the identification of biomarkers and gene expression signatures associated with disease.

28 Feb 2011

Study investigates risk of dysphagia after radiotherapy treatment for head & neck cancer

At the 3rd International Conference on innovative approaches in Head and Neck Oncology (ICHNO), Dr Hanna Rahbek Mortensen and colleagues at hospitals and institutes in Denmark presented results from a large prospective trial, the DAHANCA 6 & 7 study. The study, conducted across the country, investigated risk factors for developing dysphagia (swallowing dysfunction), after undergoing radiotherapy treatment for a head & neck cancer.

25 Feb 2011

Shock Doctor signs three-year endorsement contract with NFL

Minneapolis-based Shock Doctor – the authentic market leader and creators of innovative, unique performance-driven sports protection and the undisputed leader in mouthguard technology – announced today it has signed a three-year endorsement contract with NFL San Diego Chargers running back Ryan Mathews.

24 Feb 2011

'Current Concepts' article outlines ultrasound use among clinicians

Clinicians have often referred to ultrasound technology as the "stethoscope of the future," predicting that as the equipment shrinks in size, it will one day be as common at the bedside as that trusty tool around every physician's neck. According to a new report in The New England Journal of Medicine, that day has arrived.

24 Feb 2011

PCI Biotech completes patient inclusion in PC-A11 phase I/II study to treat cancer

PCI Biotech the Norwegian biopharmaceutical company, reported today that it has completed the inclusion of patients in its phase I/II study of its lead candidate PC-A11 in cancer patients.

23 Feb 2011

HealthGrades recognizes America's 50 Best Hospitals for 2011

HealthGrades America's 50 Best Hospitals for 2011 were identified in a report issued today by the leading independent healthcare ratings organization. These hospitals demonstrated superior and sustained clinical quality over an eleven year time period, based on an analysis of more than 140 million Medicare patient records.

23 Feb 2011